IP Library Granted Patent US 9,907,982
Granted Patent B2
US 9,907,982 · App. 15/279,514 · Granted Mar 6, 2018

Method of diagnosis and treatment of tumors using high intensity focused ultrasound

Inventors: Narendra T. Sanghvi (Indianapolis, IN); Chandan Guha (Scarsdale, NY); Russell James Fedewa (Shaker Heights, OH); Roy Francis Carlson (New Palestine, IN); Ralf Seip (Carmel, NY); Wo-Hsing Chen (Fishers, IN)
Assignees: Albert Einstein College of Medicine, Inc.; Sonacare Medical, LLC
A61N7/02A61B8/08A61B8/0833A61B18/04A61B10/007A61B10/0051A61B2017/2253A61N2007/0004A61N2007/0073A61N2007/0082
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,907,982
App. No.
15/279,514
Granted
Mar 6, 2018
Kind
B2
Abstract

A method of diagnosis and treatment of tumors using High Intensity Focused Ultrasound is provided. The method of diagnosing the presence of a tumor in a patient comprises the steps of subjecting a tumor to high intensity focused ultrasound (HIFU) to cause the tumor cells to release cellular material and evaluating the cellular material for a tumor marker. The method of treating a tumor in a patient can also comprise the step of subjecting a tumor to high intensity focused ultrasound (HIFU) to provoke an immune response.

Claims (11)

1. A method of inhibiting tumor growth in a patient, the method comprising a step of subjecting a tumor of the patient to low energy, high intensity focused ultrasound (LO-HIFU) followed after 1-7 days by a step of subjecting the tumor to high energy, high intensity focused ultrasound (HI-HIFU) in an amount effective to inhibit tumor growth in a patient, wherein the step of subjecting the tumor of the patient to LO-HIFU followed by the step of subjecting the tumor to HI-HIFU is more effective in inhibiting tumor growth than administration of either LO-HIFU alone or HI-HIFU alone.

2. The method of claim 1 , wherein HI-HIFU is administered to the patient 1-2 days after administration of LO-HIFU.

3. The method of claim 1 , wherein HI-HIFU applies power in the amount of about 1.3 to 2.0 KW per cm 2 .

4. The method of claim 1 , wherein HI-HIFU has an operating frequency of about 1.0 to 5.0 MHz.

5. The method of claim 1 , wherein HI-HIFU has an operating frequency greater than about 20 KHz and less than about 100 MHz.

6. The method of claim 1 , wherein LO-HIFU applies power in the amount of about 0.5 KW per cm 2 .

7. The method of claim 1 , wherein LO-HIFU applies energy in the amount of about 0.01 to 3.0 KW-seconds per cm 2 .

8. The method of claim 1 , wherein LO-HIFU operates with a pulse having a duration of about 0.01 to 1.0 seconds with pulse repetition frequencies of about 0.5 to 5.0 Hz.

9. The method of claim 1 , wherein LO-HIFU operates with repetition frequencies of about 0.5 to 30.0 Hz.

10. The method of claim 1 , wherein HI-HIFU operates with repetition frequencies of about 0.5 to 30.0 Hz.

11. The method of claim 1 , wherein LO-HIFU is administered at a dose that LO-HIFU treatment, in the absence of HI-HIFU treatment, is ineffective in inhibiting tumor growth, and wherein the step of subjecting the tumor of the patient to LO-HIFU followed by the step of subjecting the tumor to HI-HIFU is more effective in inhibiting tumor growth than administration of HI-HIFU alone.

Assignments (2)
MERGER Recorded Nov 3, 2021
From: SONACARE MEDICAL, LLC
To: SONABLATE CORP.
Reel/Frame 058001/0751 →
MERGER AND CHANGE OF NAME Recorded Feb 26, 2019
From: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.; ALBERT EINSTEIN COLLEGE OF MEDICINE
To: ALBERT EINSTEIN COLLEGE OF MEDICINE
Reel/Frame 048438/0275 →
Continuity (5)
Continuation 14484826 · Sep 12, 2014
Continuation 13571644 · Aug 10, 2012
Continuation 12313665 · Nov 21, 2008
Provisional Application 60989629 · Nov 21, 2007
Related Publication 20170014651A1 · Jan 19, 2017